Bain Capital Public Equity Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bain Capital Public Equity Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-400,000	Closed	-$10.3M	–	58
2013 Q4	$10.3M	Sell	400,000 -1,785,013	-82%	-$43.4M	0.29%	42
2013 Q3	$58.4M	Hold	2,185,013	–	–	1.47%	29
2013 Q2	$53.7M	Buy	+2,185,013	New	+$43.4M	1.26%	33

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bain Capital Public Equity Management's PTLA Position: Q1 2014 in Review

Bain Capital Public Equity Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2014, closing a stake of 400,000 shares — an estimated $10.3M sold.

Bain Capital Public Equity Management first reported a position in PTLA in Q2 2013 and held it in 3 quarters. The position peaked at $58.4M in Q3 2013. 102 funds tracked by Wall St. Rank hold PTLA as of Q1 2014.

Bain Capital Public Equity Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2014 after selling out during the quarter.
Bain Capital Public Equity Management sold 400,000 Portola Pharmaceuticals, Inc. shares in Q1 2014, an estimated $10.3M.
Bain Capital Public Equity Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 3 quarters.
Bain Capital Public Equity Management's Portola Pharmaceuticals, Inc. position peaked at $58.4M in Q3 2013.
102 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2014.

Based on Bain Capital Public Equity Management's 13F filing for Q1 2014, filed 9 May 2014.